$ AAPL

$ ABBV

$ ABNB

$ ACGL

$ ADI

$ ADM

$ ADP

$ ADSK

$ AEE

$ AEP

$ AES

$ AFL

$ AIG

$ AIZ

$ AJG

$ AKAM

$ ALB

$ ALGN

$ ALL

$ AMAT

$ AMCR

$ AMD

$ AME

$ AMGN

$ AMP

$ AMT

$ AMZN

$ ANET

$ AOS

$ APA

$ APD

$ APO

$ APTV

$ ARE

$ ATO

$ AVB

$ AWK

$ AXON

$ BA

$ BALL

$ BAX

$ BBY

$ BDX

$ BEN

$ BG

$ BIIB

$ BKNG

$ BLDR

$ BMY

$ BR

$ BRO

$ BXP

$ CAG

$ CAH

$ CARR

$ CAT

$ CBOE

$ CBRE

$ CCL

$ CDNS

$ CDW

$ CEG

$ CF

$ CHD

$ CHRW

$ CI

$ CINF

$ CL

$ CLX

$ CMCSA

$ CMG

$ CMI

$ CMS

$ COIN

$ COO

$ COP

$ COR

$ CPAY

$ CPT

$ CRL

$ CRWD

$ CSCO

$ CTRA

$ CTSH

$ CTVA

$ CVS

$ CVX

$ CZR

$ DAL

$ DASH

$ DAY

$ DD

$ DDOG

$ DE

$ DELL

$ DG

$ DGX

$ DIS

$ DOC

Waste Management (WM) posted a strong Q2 FY2025 beat with robust margin expansion, raised cash flow guidance, and successful healthcare integration, offsetting commodity and weather headwinds.

# Waste Management Delivers Strong Q2 FY2025 Beat with Margin Expansion and Upbeat Outlook

---

## Executive Summary

- **Waste Management (WM) delivered a robust Q2 FY2025 performance**, with revenue of **$6.43B** and adjusted EPS of **$1.92**, both exceeding consensus estimates. The company posted a **19.0% YoY revenue increase**, driven by core Collection & Disposal volume growth and the successful integration of WM Healthcare Solutions (Stericycle).
- **Earnings quality was high**, as evidenced by a 130 basis point YoY improvement in adjusted operating EBITDA margins for the legacy business (to 31.3%) and a 150 basis point reduction in operating expense margin. This margin strength was achieved despite ongoing headwinds from recycled commodity price declines.
- **Management’s tone was bullish**, with CEO Jim Fish emphasizing disciplined cost control, customer service, and innovation. The company raised its adjusted EBITDA and free cash flow guidance for FY2025, even as it trimmed revenue guidance to reflect commodity and weather uncertainties.
- **Risks remain** from continued commodity price pressures, weather-related volatility, and elevated leverage (Debt/Equity of 2.76). However, **opportunities in cost efficiencies, healthcare integration synergies, and sustainability initiatives** provide a strong foundation for future growth.
- **Catalyst watch:** Look for further updates on healthcare integration synergies and sustainability segment growth in the back half of FY2025, as well as any shifts in commodity pricing trends.

---

## Performance Snapshot

| Metric                | Reported | Consensus | Surprise | YoY Change |
|-----------------------|----------|-----------|----------|------------|
| Revenue               | $6.43B   | $6.369B   | +0.95%   | +19.0%     |
| Adjusted EPS          | $1.92    | $1.89     | +1.53%   | N/A        |
| Adj. Op. EBITDA Margin (Legacy) | 31.3% | N/A | N/A | +130 bps   |
| Operating Expense Margin (Legacy) | 59.4% | N/A | N/A | -150 bps   |
| Debt/Equity           | 2.76     | N/A       | N/A      | N/A        |

---

## Earnings Quality

Waste Management’s Q2 FY2025 results reflect **strong revenue mix and margin expansion**. The core Collection & Disposal business led growth, while the integration of WM Healthcare Solutions contributed incremental volume and synergy potential. **Cost discipline was evident**, with a 150 basis point improvement in the operating expense margin for the legacy business, offsetting recycled commodity price declines. The divergence between sales growth and profitability was positive, as margin gains outpaced revenue growth, underscoring operational leverage and effective cost management.

---

## Management Commentary & Guidance

Management’s tone was **decidedly bullish**. CEO Jim Fish highlighted disciplined cost control, customer focus, and innovation as key drivers. The company **raised its adjusted EBITDA and free cash flow guidance** for FY2025, reflecting confidence in operational execution and synergy realization from the healthcare integration (targeting $80–$100M in synergies). However, **FY2025 revenue guidance was trimmed** to $25.275–$25.475B, citing commodity price and weather uncertainties. The overall message was one of **realistic near-term caution but strong medium-term optimism**.

---

## Key Risks

- **Commodity price declines** continue to pressure recycling revenues.
- **Weather-related volatility** could impact volumes and costs, particularly in Q1.
- **Elevated leverage** (Debt/Equity of 2.76) may constrain financial flexibility if macro conditions deteriorate.
- **Regulatory and demand-side risks** remain, especially in the context of sustainability and environmental compliance.

---

## Expected Market Reaction

Analyst and investor sentiment is **broadly positive**, with several price target upgrades following the earnings release. The **strong earnings beat, margin expansion, and raised cash flow guidance** are likely to outweigh concerns about the revenue guidance cut. The stock is expected to **trend higher**, supported by bullish commentary and visible operational momentum.

---

## Final Takeaway

**Waste Management delivered a strong Q2 FY2025, marked by margin expansion, cost discipline, and successful integration of new business lines.** The market may be underestimating WM’s ability to sustain profitability and cash flow improvements despite external headwinds. Near-term risks are balanced by significant opportunities in healthcare integration and sustainability. 

**Upcoming catalysts:** 
1. Progress updates on healthcare integration synergies and sustainability segment growth.
2. Potential stabilization or improvement in recycled commodity prices.

Overall, this was a **resilient and high-quality quarter** for Waste Management, positioning the company well for the remainder of FY2025.

WM Q2 Beat: Margin Expansion & Upbeat Outlook

WM is poised for Q2 margin expansion and earnings upside, driven by strong pricing, improved internalization, and accelerating Healthcare Solutions integration, with operational leverage underappreciated by the market.

# WM’s Q2 2025 Earnings: Margin Expansion, Integration Milestones, and Underappreciated Operational Leverage

## Executive Summary

We are **bullish** on WM’s Q2 FY2025 earnings outlook, driven by robust pricing power and early signs of successful integration in the Healthcare Solutions segment. **Q1 revenue of $6.02B (+16.7% YoY)** and a **6.5% core price increase** set a strong foundation for sequential growth. Management’s confident tone and reaffirmed full-year guidance suggest upside risk to consensus, particularly as **internalization rates improve** and margin expansion accelerates. The market may be underestimating the near-term earnings impact from operational efficiencies—specifically, the **2.4 percentage point increase in waste internalization**—which could drive both revenue consistency and cost leverage in Q2.

## Recent Trends Signal What’s Next

WM’s last two quarters have demonstrated a clear upward trajectory in both revenue and profitability, underpinned by aggressive pricing and improving segment performance. **Q1 FY2025 revenue reached $6.02B** (up from $5.16B in Q4 FY2024), with **operating margin expanding to 16.8%**. The Collection and Disposal segment remains the primary growth engine, while Healthcare Solutions is beginning to narrow its integration drag. The following table summarizes the last four quarters’ key financials, highlighting the positive trend:

### Revenue, Margin, and EPS Trend Table

| Quarter      | Revenue ($B) | Gross Margin (%) | Operating Margin (%) | Net Margin (%) | EPS ($) |
|--------------|--------------|------------------|----------------------|---------------|---------|
| Q3 FY2024    | 5.08         | 38.2             | 15.9                 | 10.7          | 1.72    |
| Q4 FY2024    | 5.16         | 38.5             | 16.1                 | 11.0          | 1.75    |
| Q1 FY2025    | 6.02         | 39.0             | 16.8                 | 11.5          | 1.89    |
| Q2 FY2025E   | 6.10*        | 39.5*            | 17.0*                | 12.0*         | 1.92*   |

*Estimates based on current trends and management guidance.

## Management’s Forward Tone and Positioning

Management’s communication has shifted from cautious optimism to clear confidence. In the Q1 2025 earnings call, leadership stated, **“We’re seeing a clear path to synergy realization in Healthcare Solutions and remain on track for our full-year margin targets.”** This is a notable change from the prior quarter’s more guarded language around integration risks. The repeated use of terms like **“resilient demand,” “strong pricing,”** and **“on track”** for integration milestones signals a higher degree of visibility and conviction in near-term performance. Compared to Q4, when management emphasized “monitoring cost pressures,” the current tone is more focused on execution and upside delivery.

## KPI Trends & Upcoming Quarter Drivers

Three KPIs are set to drive Q2 results:

- **Internalization Rate:** Rose from **68.3% in Q4 FY2024 to 70.7% in Q1 FY2025**. This improvement enhances cost control and revenue capture.
- **Core Price/Yield:** **6.5% core price increase** and **4.0% yield improvement** in Q1, both expected to persist into Q2, supporting margin expansion.
- **Special Waste Volumes:** Flat overall volumes, but special waste saw a boost from external events, providing a potential Q2 tailwind if such events recur.

### KPI Movement Table

| KPI                   | Q1 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025E |
|-----------------------|-----------|-----------|-----------|------------|
| Internalization Rate  | 67.8%     | 68.3%     | 70.7%     | 71.0%*     |
| Core Price Increase   | 5.8%      | 6.0%      | 6.5%      | 6.5%*      |
| Yield Improvement     | 3.5%      | 3.8%      | 4.0%      | 4.1%*      |

*Estimates based on current trajectory.

Each of these KPIs directly supports higher revenue and margin, with internalization also reducing exposure to third-party disposal costs.

## Missed by the Street

Two underappreciated signals stand out:

- **Operational Leverage from Internalization:** The **2.4 percentage point jump in internalization** is not fully reflected in consensus models, yet it is a key driver of both cost efficiency and pricing power.
- **Accelerating Healthcare Synergies:** Management’s reference to a **“clear path”** for Healthcare Solutions integration suggests synergy benefits may materialize faster than expected, potentially lifting adjusted margins ahead of schedule.

## Scenarios for the Upcoming Quarter

### Scenario Table

| Scenario | Total Revenue ($B) | GAAP EPS | Operating Margin | Key Assumptions                                                      |
|----------|-------------------|----------|------------------|----------------------------------------------------------------------|
| Bull     | 6.20              | 1.95     | 17.5%            | Accelerated Healthcare synergies, sustained pricing, muted cost headwinds |
| Base     | 6.00              | 1.89     | 16.8%            | Steady integration, continued pricing, normal cost environment        |
| Bear     | 5.80              | 1.80     | 16.0%            | Integration delays, higher cost inflation, weaker special waste volumes |

**Base case** is most likely, given current evidence of stable pricing, visible integration progress, and management’s reaffirmed guidance. Upside risk exists if Healthcare synergies accelerate further.

## Appendix – Data Tables & Management Quotes

### Quarterly Revenue, EPS, and Margin Table

| Quarter      | Revenue ($B) | EPS ($) | Operating Margin (%) |
|--------------|--------------|---------|----------------------|
| Q3 FY2024    | 5.08         | 1.72    | 15.9                 |
| Q4 FY2024    | 5.16         | 1.75    | 16.1                 |
| Q1 FY2025    | 6.02         | 1.89    | 16.8                 |
| Q2 FY2025E   | 6.10*        | 1.92*   | 17.0*                |

### KPI Movement Table

| KPI                   | Q1 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025E |
|-----------------------|-----------|-----------|-----------|------------|
| Internalization Rate  | 67.8%     | 68.3%     | 70.7%     | 71.0%*     |
| Core Price Increase   | 5.8%      | 6.0%      | 6.5%      | 6.5%*      |
| Yield Improvement     | 3.5%      | 3.8%      | 4.0%      | 4.1%*      |

### Key Management Quotes

1. **“We’re seeing a clear path to synergy realization in Healthcare Solutions and remain on track for our full-year margin targets.”**  
   *Q1 2025 Earnings Call* — Signals confidence in integration and margin expansion.

2. **“Core price increases of 6.5% reflect our ability to pass through inflationary pressures.”**  
   *Q1 2025 Earnings Call* — Underlines pricing power and cost management.

3. **“Internalization improved to 70.7%, enhancing our control over disposal costs.”**  
   *Q1 2025 Earnings Call* — Highlights operational leverage.

4. **“We continue to invest in automation and technology to drive productivity.”**  
   *Q1 2025 Earnings Call* — Suggests ongoing efficiency gains.

5. **“We are on track with our capex plan, including $128M in sustainability projects this quarter.”**  
   *Q1 2025 Earnings Call* — Indicates disciplined capital allocation.

6. **“Special waste volumes benefited from external events, providing a near-term tailwind.”**  
   *Q1 2025 Earnings Call* — Points to potential upside if such events recur.

7. **“We are closely monitoring regulatory developments, including EPA PFAS rules.”**  
   *Q1 2025 Earnings Call* — Acknowledges regulatory risk.

---

**Bottom Line:** WM’s Q2 is set up for continued revenue and margin gains, with operational improvements and integration milestones as key catalysts. The Street may be underestimating the near-term earnings leverage from internalization and synergy realization.

WM: Margin Expansion & Healthcare Synergy Upside